Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hematologic Diseases × Albumins × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Hematologic Diseases 1

Interventions

Brentuximab Vedotin 14 fludarabine 8 Cyclophosphamide 8 Bortezomib 6 ruxolitinib 5 fludarabine phosphate 5 dacetuzumab 5 Melphalan 5 Lenalidomide 5 Rituximab 4 Dexamethasone 4 Busulfan 4 lintuzumab 3 Whole-Body Irradiation 3 Mycophenolic Acid 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Calcium Dobesilate 3 Azacitidine 3 vosaroxin 2 spartalizumab 2 ponatinib 2 nilotinib 2 Vincristine 2 Thiotepa 2 Tacrolimus 2 Sugars 2 Prednisone 2 KW-2478 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06095752 2025-10-02

Multiple Myeloma Prognostic Indices

Assiut University

Hematologic Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡